Review article · 2023 · Open access
TACkling Cancer by Targeting Selective Protein Degradation
Pharmaceutics, 15(10), 2442 · Published 10 October 2023 · DOI 10.3390/pharmaceutics15102442
In brief
“TACkling Cancer by Targeting Selective Protein Degradation” is a 2023 review article by María del Mar Noblejas‐López and 7 co-authors, published in Pharmaceutics. OpenAlex counts 30 citations as of 21 November 2026, which puts it in the top 2% of works published in 2023 by citations. It is open access under a CC BY licence: the full text is free to read at Pharmaceutics.
- Citations
- 30
- Most cited in
- 2025 (16)
- Field-weighted impact
- 0.68
- References
- 89
- Authors
- 8
Abstract
Targeted protein degradation has emerged as an alternative therapy against cancer, offering several advantages over traditional inhibitors. The new degrader drugs provide different therapeutic strategies: they could cross the phospholipid bilayer membrane by the addition of specific moieties to extracellular proteins. On the other hand, they could efficiently improve the degradation process by the generation of a ternary complex structure of an E3 ligase. Herein, we review the current trends in the use of TAC-based technologies (TACnologies), such as PROteolysis TArgeting Chimeras (PROTAC), PHOtochemically TArgeting Chimeras (PHOTAC), CLIck-formed Proteolysis TArgeting Chimeras (CLIPTAC), AUtophagy TArgeting Chimeras (AUTAC), AuTophagosome TEthering Compounds (ATTEC), LYsosome-TArgeting Chimeras (LYTAC), and DeUBiquitinase TArgeting Chimeras (DUBTAC), in experimental development and their progress towards clinical applications.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Noblejas‐López, M. D. M., Tébar-García, D., López‐Rosa, R., Alcaraz-Sanabria, A. L., Cristóbal‐Cueto, P., Pinedo‐Serrano, A., Rivas‐García, L., & Galán‐Moya, E. M. (2023). TACkling Cancer by Targeting Selective Protein Degradation. Pharmaceutics, 15(10), 2442. https://doi.org/10.3390/pharmaceutics15102442
MLA 9
Noblejas‐López, María del Mar, et al. “TACkling Cancer by Targeting Selective Protein Degradation.” Pharmaceutics, vol. 15, no. 10, 2023, p. 2442. https://doi.org/10.3390/pharmaceutics15102442.
Chicago
Noblejas‐López, María del Mar, David Tébar-García, Raquel López‐Rosa, Ana Lucía Alcaraz-Sanabria, Pablo Cristóbal‐Cueto, Alejandro Pinedo‐Serrano, Lorenzo Rivas‐García, and Eva María Galán‐Moya. 2023. “TACkling Cancer by Targeting Selective Protein Degradation.” Pharmaceutics 15 (10): 2442. https://doi.org/10.3390/pharmaceutics15102442.
Harvard
Noblejas‐López, M. D. M. et al. (2023) ‘TACkling Cancer by Targeting Selective Protein Degradation’, Pharmaceutics, 15(10), p. 2442. doi:10.3390/pharmaceutics15102442.
IEEE
M. D. M. Noblejas‐López et al., “TACkling Cancer by Targeting Selective Protein Degradation,” Pharmaceutics, vol. 15, no. 10, p. 2442, 2023, doi: 10.3390/pharmaceutics15102442.
BibTeX
@article{noblejaslopez2023tackling,
title = {{TACkling Cancer by Targeting Selective Protein Degradation}},
author = {Noblejas‐López, María del Mar and Tébar-García, David and López‐Rosa, Raquel and Alcaraz-Sanabria, Ana Lucía and Cristóbal‐Cueto, Pablo and Pinedo‐Serrano, Alejandro and Rivas‐García, Lorenzo and Galán‐Moya, Eva María},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {10},
pages = {2442},
doi = {10.3390/pharmaceutics15102442},
url = {https://doi.org/10.3390/pharmaceutics15102442}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2024 | 8 | |
| 2025 | 16 | |
| 2026 | 6 |
Its field-weighted citation impact is 0.68: it has been cited 0.68 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- targeted protein degradation
- PROTACs
- lysosome-targeting chimeras
- E3 ubiquitin ligase
- cancer therapy
- lysosomal targeting
- clinical development
Work with this paper
Most-cited papers in Biochemistry, Genetics and Molecular Biology
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTOliver H. Lowry, NiraJ. Rosebrough, A. Lewis Farr and 1 more · Journal of Biological Chemistry · 1951 · 316,470 citations
- A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye BindingM Bradford · Analytical Biochemistry · 1976 · 256,780 citations
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodKenneth J. Livak, Thomas D. Schmittgen · Methods · 2001 · 184,418 citations
- Molecular Cloning: A Laboratory ManualJoseph Sambrook, Elisabeth Fritsch, Tom Maniatis · UCLA - Biblioteca de Ciencias de la Salud · 1989 · 133,493 citations
- Basic Local Alignment Search ToolStephen F. Altschul, Warren R. Gish, Webb Miller and 2 more · Journal of Molecular Biology · 1990 · 100,529 citations
All highly cited Biochemistry, Genetics and Molecular Biology papers
Questions about this paper
How do I cite this paper in APA style?
Noblejas‐López, M. D. M., Tébar-García, D., López‐Rosa, R., Alcaraz-Sanabria, A. L., Cristóbal‐Cueto, P., Pinedo‐Serrano, A., Rivas‐García, L., & Galán‐Moya, E. M. (2023). TACkling Cancer by Targeting Selective Protein Degradation. Pharmaceutics, 15(10), 2442. https://doi.org/10.3390/pharmaceutics15102442
How many times has this paper been cited?
30 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Pharmaceutics: sign in and open the PDF from this page.
Who wrote this paper?
María del Mar Noblejas‐López, David Tébar-García, Raquel López‐Rosa, Ana Lucía Alcaraz-Sanabria, Pablo Cristóbal‐Cueto, Alejandro Pinedo‐Serrano, Lorenzo Rivas‐García, Eva María Galán‐Moya.
What is the DOI of this paper?
10.3390/pharmaceutics15102442, permanently at https://doi.org/10.3390/pharmaceutics15102442. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.